Lung Cancer

Premedication With Dexamethasone May Prevent Pemetrexed-Associated Skin Rash

By

Vicki Moore, PhD

Publish Date August 20, 2019

A retrospective study sought to determine the efficacy of dexamethasone in preventing cutaneous reactions associated with pemetrexed-based regimens for pulmonary adenocarcinoma.

Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval

By

Brian Park, PharmD

Publish Date August 16, 2019

The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)

AI Tool Discerns Lung Cancer Outcomes From Imaging Reports

Publish Date August 16, 2019

Deep natural language processing used to detect presence of lung cancer and treatment response.

Image-Based Model Predicts Radiation Tx Failure in Lung Cancer

Publish Date August 6, 2019

Higher rate of treatment failure for lung cancer patients with high Deep Profiler scores.

Model Can Predict Lung Cancer in Patient With Visible Nodule on CT

Publish Date August 6, 2019

Combination of clinical and radiologic factors can reliably predict risk for incident lung cancer.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)